China's Pharmaceutical Companies Could See Wave of Project Completions in 2022

BEIJING--December 30, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Many Chinese pharmaceutical projects tracked by Industrial Info over the past two years have faced delays due to the COVID-19 pandemic. Many of these projects will be completed before the end of 2022, and 793 projects totaling more than $42 billion in value are expected to kick off in 2022.